2. Early access

View

3. Compassionate use

3.3. Patient access

In general, medicines that have not been authorised are first made available to patients through clinical trials, and the doctor will first advise the patient on whether there is a suitable clinical trial in their country that they can enter and on how compassionate use programmes work in their country. If an appropriate CUP exists, he can speak to the responsible company and find out whether his patient can be enrolled.